DK116675B - Fremgangsmåde til fremstilling af praktisk taget ren, krystallinsk kallikrein-inaktivator. - Google Patents

Fremgangsmåde til fremstilling af praktisk taget ren, krystallinsk kallikrein-inaktivator.

Info

Publication number
DK116675B
DK116675B DK96367AA DK96367A DK116675B DK 116675 B DK116675 B DK 116675B DK 96367A A DK96367A A DK 96367AA DK 96367 A DK96367 A DK 96367A DK 116675 B DK116675 B DK 116675B
Authority
DK
Denmark
Prior art keywords
preparation
pure crystalline
practically pure
kallikrein inactivator
inactivator
Prior art date
Application number
DK96367AA
Other languages
English (en)
Inventor
F Schultz
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of DK116675B publication Critical patent/DK116675B/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811Serine protease (E.C. 3.4.21) inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • A61K38/57Protease inhibitors from animals; from humans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/18Ion-exchange chromatography

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Analytical Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Purses, Travelling Bags, Baskets, Or Suitcases (AREA)
  • Peptides Or Proteins (AREA)
DK96367AA 1966-02-23 1967-02-22 Fremgangsmåde til fremstilling af praktisk taget ren, krystallinsk kallikrein-inaktivator. DK116675B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEF0048504 1966-02-23

Publications (1)

Publication Number Publication Date
DK116675B true DK116675B (da) 1970-02-02

Family

ID=7102287

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96367AA DK116675B (da) 1966-02-23 1967-02-22 Fremgangsmåde til fremstilling af praktisk taget ren, krystallinsk kallikrein-inaktivator.

Country Status (16)

Country Link
US (1) US3558773A (da)
AT (1) AT267050B (da)
BE (1) BE694474A (da)
CH (1) CH483258A (da)
DE (1) DE1252364B (da)
DK (1) DK116675B (da)
ES (1) ES337146A1 (da)
FI (1) FI45827C (da)
FR (2) FR1512258A (da)
GB (1) GB1134486A (da)
IL (1) IL27383A (da)
LU (1) LU53052A1 (da)
NL (1) NL6702824A (da)
NO (1) NO119755B (da)
SE (1) SE325369B (da)
YU (2) YU29467A (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1517753B2 (de) * 1966-05-26 1973-11-29 Bayer Ag, 5090 Leverkusen Verfahren zur Anreicherung von Enzym Inhibitoren
BE754278A (fr) * 1969-08-02 1971-02-01 Bayer Ag Procede d'utilisation d'inhibiteurs biologiques de proteases comme desodorisants
US3951939A (en) * 1972-01-08 1976-04-20 Behringwerke Aktiengesellschaft Polypeptides, process for their manufacture and their use as polyvalent isoinhibitors
JPS5544726B2 (da) * 1973-05-17 1980-11-13
NL7411563A (nl) * 1973-09-06 1975-03-10 Hoechst Ag Werkwijze voor het bereiden van synthetisch gemodificeerde trypsine-inhibitoren.
US4190573A (en) * 1974-02-14 1980-02-26 Behringwerke Aktiengesellschaft Process for the isolation of the polyvalent proteinase inhibitor
FR2701258B1 (fr) * 1993-02-09 1995-04-28 Inst Francais Du Petrole Procédé continu pour l'isomérisation des oléfines.
WO1998003537A2 (en) * 1996-07-24 1998-01-29 Novartis Ag Hirustasin and a hirustasin/kallikrein complex in crystalline form
US7552776B2 (en) * 1998-12-07 2009-06-30 Enventure Global Technology, Llc Anchor hangers

Also Published As

Publication number Publication date
ES337146A1 (es) 1968-06-01
BE694474A (da) 1967-08-22
NL6702824A (da) 1967-08-24
FI45827B (da) 1972-06-30
IL27383A (en) 1970-09-17
LU53052A1 (da) 1967-04-24
CH483258A (de) 1969-12-31
YU33199B (en) 1976-06-30
GB1134486A (en) 1968-11-27
SE325369B (da) 1970-06-29
AT267050B (de) 1968-12-10
DE1252364B (de) 1967-10-19
US3558773A (en) 1971-01-26
FR7027M (da) 1969-06-09
FR1512258A (fr) 1968-02-02
FI45827C (fi) 1972-10-10
NO119755B (da) 1970-06-29
YU29467A (en) 1975-12-31

Similar Documents

Publication Publication Date Title
DK111568B (da) Fremgangsmåde til fremstilling af N-alkyl-3,1-benzoxazin-2-oner.
DK119005B (da) Fremgangsmåde til fremstilling af 3-alkoxy-13-alkylgona-1,3,5(10),8,14-penten-17-oner.
DK116675B (da) Fremgangsmåde til fremstilling af praktisk taget ren, krystallinsk kallikrein-inaktivator.
DK120489B (da) Analogifremgangsmåde til fremstilling af 17α-alkenyl- eller -alkynyl-11,13β-dialkylgon-4-en-3,17β-dioler eller estere deraf.
DK114767B (da) Analogifremgangsmåde til fremstilling af 1,1-diphenyl-2-methyl-3-(benzylidenamino)propanoler.
DK127971B (da) Analogifremgangsmåde til fremstilling af halogenmethyl-1,3-polyhalogen-2-propylethere.
DK116736B (da) Fremgangsmåde til fremstilling af 5-chlor-2,3-pyridindiol.
DK120347B (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepin-4-oxider.
DK116357B (da) Fremgangsmåde til fremstilling af 1,1,1,2,2-pentafluor-3-chlorpropan.
DK115551B (da) Fremgangsmåde til fremstilling af 6-aminouracil-5-carbonamid-N-sulfonamider.
DK126105B (da) Fremgangsmåde til fremstilling af meget ren 2,6-xylenol.
DK115622B (da) Fremgangsmåde til fremstilling af 3-oxogona-4,9,11-triener.
DK120131B (da) Fremgangsmåde til fremstilling af 3-oxo-13β-alkylgona-4,9,11-triener.
DK119826B (da) Fremgangsmåde til fremstilling af α-6-deoxytetracyclin, α-6-deoxy-5-oxytetracyclin eller syreadditionssalte deraf.
DK114063B (da) Fremgangsmåde til fremstilling af 1-methyl-2-isopropyl-5-nitro-imidazol.
DK117955B (da) Analogifremgangsmåde til fremstilling af N<4>-acrylerede 1-halogenbenzen-2,4-disulfonamider.
DK127418B (da) Fremgangsmåde til fremstilling af 13-alkyl-gona-1,3,5(10),6,8,14-hexaener.
DK102820C (da) Fremgangsmåde til fremstilling af rene præparater af kallikrein-inaktivatoren.
DK116368B (da) Fremgangsmåde til fremstilling af 2,3-dihydro-2,2,4-trimethyl-7-benzofuranol.
DK118949B (da) Fremgangsmåde til fremstilling af 2-alkyl-3-phenyl-4(3H)-quinazolinoner.
DK119830B (da) Analogifremgangsmåde til fremstilling af arylsulfonylsemicarbazider.
DK114626B (da) Fremgangsmåde til fremstilling af 2-substitueret-4-amino-5-acylamidometylpyrimidin.
DK122389B (da) Analogifremgangsmåde til fremstilling af chlorbenzen-2,4-disulfonamider.
DK116659B (da) Fremgangsmåde til fremstilling af 9α-hydroxy-11β-nitro-1,3,5(10)-østratriener.
DK116735B (da) Fremgangsmåde til fremstilling af Δ<14>-pregnen-3,21-diol-20-on-21-acylater.